Doxazosin Tablets recall (Unichem Pharmaceuticals USA Inc.)
DrugClass IIIOngoing
Summary: Unichem Pharmaceuticals USA Inc. is recalling Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa . Reason: Tablets/Capsules Imprinted with Wrong ID.
What is being recalled
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pilerne Industrial Estate, Pilerne, Bardez, Goa (India) 403511, NDC 29300-353-10.
Why
Tablets/Capsules Imprinted with Wrong ID
How serious is it
Class III is the least serious level: using or being exposed to this product is not likely to cause health problems, but it breaks FDA rules.
Where it was sold
Nationwide
How to tell if yours is affected
Lot # GDSH25006, Exp Date: 08/2027
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0306-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class III |
| Status | Ongoing |
| Recall started | January 21, 2026 |
| Reported | February 18, 2026 |
| Company | Unichem Pharmaceuticals USA Inc. |
| Company location | East Brunswick, NJ, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 60,000 tablets |
More recalls from Unichem Pharmaceuticals USA Inc. · all drug recalls · recalls from January 2026